Maxiflo 250 Inhaler
Generic: Fluticasone/formoterolby Cipla Limited

Similar medicines
View allAbout Maxiflo 250 Inhaler
Maxiflo 250 Inhaler is a pressurised metered dose inhaler (a "puffer") made in India by Cipla. According to Cipla's prescribing information, each puff delivers 250 mcg of fluticasone propionate, an inhaled steroid, and 6 mcg of formoterol fumarate dihydrate, a long-acting bronchodilator, suspended in an HFA 134a propellant. One canister gives 120 metered doses and has a dose counter. It is a twice daily asthma preventer, not a reliever. We sell 1, 2 or 3 inhalers, from $23.67 an inhaler (about $0.20 a puff) in the 3 pack.
Read this first. No inhaler with these exact numbers is licensed in the US, UK, Australia or Canada. The licensed version of the combination is Flutiform (UK and Australia, asthma only), and its strongest strength, 250/10, puts more formoterol into each puff than Maxiflo 250. The FDA and Health Canada have not approved any fluticasone with formoterol product. Cipla also lists this inhaler for severe COPD, which the UK Flutiform label rules out for lack of data.
Below: what Cipla's "each actuation delivers" wording means, price per inhaler and per puff, how it compares with Flutiform and with the inhalers US patients are prescribed, how to prime and use a puffer, spacers, side effects, who should not use it and when to get urgent help. Clinical statements come from Cipla's Maxiflo Inhaler prescribing information and the UK summary of product characteristics (SmPC) for Flutiform, listed under Sources. We have not found a published study comparing Maxiflo Inhaler with Flutiform. The same medicine also comes as capsules for a Rotahaler: see Maxiflo 250 Rotacaps.
Maxiflo 250 Inhaler at a glance
| Active ingredients | Fluticasone propionate 250 mcg and formoterol fumarate dihydrate 6 mcg delivered per actuation (Cipla prescribing information); PharmEasy, Apollo and MediBuddy list the same two amounts |
| Brand and maker | Maxiflo, Cipla Limited, India |
| Form | Pressurised metered dose inhaler, HFA 134a propellant, 120 metered doses, dose counter (Cipla; the carton in our product photo reads "120 metered doses" and "with dose counter") |
| Used for | Regular maintenance treatment of asthma when a steroid plus long-acting bronchodilator is appropriate; Cipla also lists severe COPD. Not for attacks. |
| Regulatory status | The combination is licensed in the UK and Australia as Flutiform (asthma only). No fluticasone with formoterol product is approved by the FDA or authorised by Health Canada. This Indian Maxiflo inhaler is not registered with the FDA, MHRA, TGA or Health Canada. |
| Usual dose (Cipla) | Asthma, age 12 and over: 1 to 2 puffs twice a day. COPD: 2 puffs twice a day. |
| Onset and duration | Cipla: formoterol opens the airways within 1 to 3 minutes of a single dose, for at least 12 hours. Still not a reliever (see below). |
| Packs | 1, 2 or 3 inhalers of 120 puffs; one inhaler lasts 60 days at 1 puff twice a day or 30 days at 2 puffs twice a day (our arithmetic) |
| Price | $32 for one inhaler down to $23.67 an inhaler in the 3 pack, before shipping |
| Delivery | 7 to 14 business days to the US, UK, Australia and Canada; $25 shipping under $149, free from $149 |
Price per inhaler and per puff
Prices as of November 2026; the pack selector shows the current price.
| Pack | Price | Per inhaler | Per puff | With $25 shipping, per inhaler | With shipping, per puff | Lasts at 2 puffs twice a day |
|---|---|---|---|---|---|---|
| 1 inhaler (120 puffs) | $32 | $32.00 | $0.27 | $57.00 | $0.48 | 30 days |
| 2 inhalers (240 puffs) | $49 | $24.50 | $0.20 | $37.00 | $0.31 | 60 days |
| 3 inhalers (360 puffs) | $71 | $23.67 | $0.20 | $32.00 | $0.27 | 90 days |
Every pack is below the $149 free shipping level, so each order carries the flat $25. On a single inhaler that adds 78% to the price; spread over three it adds about $8.33 an inhaler. The 2 and 3 packs are already cheaper per inhaler before shipping, so the saving is not only about shipping. Per puff and per day figures are our arithmetic. If your leaflet asks you to prime the inhaler by firing test puffs, those puffs may come out of the 120; we could not confirm how Cipla's counter treats them.
At 2 puffs twice a day, one inhaler lasts 30 days, which leaves little margin over a 7 to 14 business day delivery time. If that is your dose, the 2 or 3 pack is the more practical order.
Inhaler or Rotacaps?
Cipla sells the same two medicines in two devices. The numbers look alike but are counted differently:
| Maxiflo 250 Inhaler (this page) | Maxiflo 250 Rotacaps | |
|---|---|---|
| Device | Pressurised puffer, press and breathe in slowly | Powder capsules in a Rotahaler, breathe in fast and deep |
| How Cipla states the dose | "Each actuation delivers" 250 mcg / 6 mcg | "Each capsule contains" 250 mcg / 6 mcg |
| Hand and breath timing | You must press and inhale together; Cipla says a spacer can help if this is hard | Breath triggers the dose; no timing needed, but a strong breath is |
| Extra device needed | No (spacer optional) | Yes, a Rotahaler |
| Our price per dose, before shipping | $0.20 to $0.27 a puff | $0.42 to $0.57 a capsule |
On our current prices the inhaler costs less per dose than the capsules (our arithmetic). Price should not decide the device, though: the right one is the one you can use well, and changing device is something to agree with your doctor or asthma nurse. Our guide Rotacaps vs inhaler vs respules compares the devices in more detail.
What "each actuation delivers" means
Inhalers can be labelled by what the valve measures out (metered dose) or by what leaves the mouthpiece (delivered dose). The difference matters when you compare products:
- Maxiflo 250 Inhaler: Cipla's composition says "each actuation delivers" 250 mcg fluticasone propionate and 6 mcg formoterol fumarate dihydrate. Read literally, that is a delivered figure. Cipla does not give a separate metered figure.
- Flutiform 250/10 (UK): 250 mcg and 10 mcg metered per puff, which the UK SmPC says equals a delivered dose of about 230 mcg fluticasone propionate and 9.0 mcg formoterol fumarate dihydrate.
- Advair HFA 230/21 (US): the US label gives 230 mcg fluticasone propionate and 21 mcg salmeterol "from the actuator", and 250 mcg and 25 mcg "from the valve".
Taking Cipla's wording at face value, one Maxiflo 250 puff carries a fluticasone dose close to one Flutiform 250/10 puff, and about two thirds of its formoterol (6 against about 9.0 mcg delivered; our arithmetic). That is a comparison of label numbers, not proof of what reaches the lungs; no study we found has measured both products side by side.
Compared with Flutiform and US inhalers
| Maxiflo 250 Inhaler | Flutiform 250/10 | Advair HFA 230/21 and its generic | Dulera 200/5 | |
|---|---|---|---|---|
| Medicines | Fluticasone propionate + formoterol | Fluticasone propionate + formoterol | Fluticasone propionate + salmeterol | Mometasone furoate + formoterol |
| Where licensed | India (CDSCO) | UK, Australia | US | US |
| Licensed use | Asthma 12+; severe COPD (Cipla) | Asthma, adults only for this strength (UK) | Asthma, 12 and over (US label) | Asthma, 5 and over (US label) |
| Puffs per inhaler | 120 | 120 | 120 (12 g canister) | 120 (13 g canister) |
| Cost per 120 puff inhaler | $32 before shipping; $23.67 each in a 3 pack | Not sold in the US | Advair HFA about $420.10; generic about $325.83 (NADAC) | About $327.28 (NADAC) |
NADAC is the average price US pharmacies pay to buy a medicine, not what a patient pays at the counter. Our figures multiply the NADAC price per gram by the canister weight in each US label: Advair HFA 230/21 $35.00808/g, generic fluticasone propionate and salmeterol HFA 230/21 $27.15260/g, Dulera 200/5 $25.17560/g, all effective 21 October 2026 (our arithmetic). Neither US product is the same medicine as Maxiflo: one swaps formoterol for salmeterol, the other swaps fluticasone for mometasone, so a US prescription for either is not a prescription for Maxiflo. Even so, the US pharmacy acquisition cost of these inhalers is at least ten times our single inhaler price before shipping. If you have US insurance, check your copay first; it may be lower than our price with shipping. Any switch between these products is your prescriber's call.
Which strength to choose
| Product | Per puff or capsule (Cipla) | Daily fluticasone at 1 puff or capsule twice a day | At 2 twice a day |
|---|---|---|---|
| Maxiflo 125 Inhaler | 125 mcg / 6 mcg delivered | 250 mcg (GINA low) | 500 mcg (GINA medium) |
| Maxiflo 250 Inhaler (this page) | 250 mcg / 6 mcg delivered | 500 mcg (GINA medium) | 1,000 mcg (GINA high) |
| Maxiflo 100 Rotacap | 100 mcg / 6 mcg per capsule | 200 mcg | 400 mcg |
| Maxiflo 250 Rotacaps | 250 mcg / 6 mcg per capsule | 500 mcg | 1,000 mcg |
The GINA 2026 report lists fluticasone propionate from an HFA puffer at 100 to 250 mcg a day as low, above 250 to 500 as medium and above 500 as high for adults and adolescents. GINA says its table shows suggested doses, not equivalence, and is based on metered doses, so treat our bands as a guide. At 2 puffs twice a day, Maxiflo 250 is a high steroid dose. Cipla notes that some adults on higher doses (for example more than 1 mg a day) may show some fall in cortisol. The UK Flutiform label keeps the 250/10 strength for adults only and says the dose "should be titrated to the lowest dose at which effective control of symptoms is maintained"; Cipla suggests stepping down after about 3 months of good control. Changing strength is a decision for your doctor.
Severe COPD: where the labels part ways
Cipla's indication includes "patients with severe COPD", with a dose of 2 puffs twice a day, and India's drug regulator approved formoterol 6 mcg with fluticasone propionate 50, 125 or 250 mcg as a metered dose inhaler "For Asthma & COPD" on 14 October 2006 (CDSCO list, item 582). In the UK, the Flutiform SmPC (section 4.2) states: "There are no data available for use of Flutiform inhaler in patients with COPD. Flutiform inhaler should not be used in patients with COPD." Australia lists Flutiform for asthma only. If COPD is your diagnosis, talk to your doctor before using this inhaler; each of the four countries we ship to has licensed COPD inhalers with other ingredients.
A preventer, not a rescue inhaler
- Cipla: Maxiflo Inhaler "should not be used to treat acute asthma symptoms for which a fast and short-acting bronchodilator is required", and patients should keep their relief medicine "available at all times". Carry a reliever such as an Asthalin (salbutamol) inhaler.
- Cipla: it "must be used daily for optimum benefit, even when asymptomatic".
- Cipla and the UK label: do not start it during a flare or when asthma is getting significantly worse; serious asthma-related events and flares may occur during treatment.
- UK label: combinations like this "should not be used as the first treatment for asthma"; inhaled steroids alone come first for most people.
- UK label: no other long-acting beta agonist "for any reason". Do not add salmeterol or another formoterol inhaler.
- Cipla: its use to prevent exercise-induced asthma "has not been studied".
- Cipla: do not stop suddenly; reduce only under a doctor's supervision. Needing your reliever more often "indicates a deterioration of asthma control" and calls for a review.
How to use the Maxiflo 250 Inhaler
Cipla's prescribing information gives no step by step method or priming count, so follow the leaflet in your carton. The steps below are the UK Flutiform method for the same kind of puffer (SmPC section 4.2), which is a reasonable guide:
- Prime it when new, or if unused for 3 days or more, or after it has been cold: remove the cap, shake well and fire puffs into the air away from your face. Flutiform uses 4 priming puffs; check the Maxiflo leaflet for its number.
- Shake the inhaler immediately before every puff.
- Sit or stand upright and breathe out as far as is comfortable.
- Hold it upright, canister on top, and close your lips around the mouthpiece without biting it.
- Start breathing in slowly and deeply through your mouth, then press the canister once while you keep breathing in steadily (the UK label suggests about 4 to 5 seconds for adults).
- Hold your breath as long as is comfortable, with the inhaler out of your mouth. Do not breathe out into it.
- For a second puff, keep the inhaler upright and repeat from the shake step. Do not rush.
- Replace the cap, then rinse your mouth, gargle with water or brush your teeth and spit out (UK label), which lowers the risk of thrush and hoarseness.
- Take it morning and evening, every day, even when you feel well.
If you see mist coming from the top of the inhaler or the corners of your mouth, the UK label says to repeat the puff from the shake step. It also suggests practising in front of a mirror, and holding the inhaler with both hands if your grip is weak. Cleaning (Cipla dose counter guide): at least once a week, take the cap off and wipe inside and outside the mouthpiece with a clean, dry cloth; do not take the metal canister out and do not wash or soak any part in water.
The counter. Cipla's dose counter guide says the counter turns from green to red when 40 puffs remain, and that at "0" there is no medicine left and the inhaler should be discarded, even if it still sprays. Given our delivery time, reorder when it turns red (our advice).
Spacers
Cipla says Maxiflo Inhaler "may be used with a Zerostat VT Spacer device" if you find it hard to press and breathe in at the same moment. PharmEasy's listing recommends transparent, non-static spacers. The UK Flutiform label names the AeroChamber Plus Flow-Vu and adds three points worth knowing:
- with that spacer, the fluticasone that reached the bloodstream (a measure of the dose reaching the lungs) rose by 35% on average in healthy volunteers;
- a spacer "may lead to a possible increase in pulmonary deposition and a potential increase in systemic absorption and systemic adverse events";
- the dose should be re-titrated to the lowest effective dose after a spacer is introduced.
GINA 2026 says a spacer should be used for inhaled steroids given by puffer. In practice: do not start or stop using a spacer without telling your doctor, because the amount you inhale can change. We do not sell spacers; pharmacies carry them.
Groups who need extra care
- Heart conditions (Cipla): caution with QTc prolongation, ischaemic heart disease, arrhythmias, severe heart failure, severe hypertension, aneurysm, hypertrophic obstructive cardiomyopathy or subvalvular aortic stenosis. "Formoterol itself may induce prolongation of the QTc interval."
- Thyroid and adrenal tumours (Cipla): caution with past thyrotoxicosis or a phaeochromocytoma.
- Low potassium (Cipla): xanthines such as theophylline, steroids and diuretics may add to the fall; Cipla recommends checking potassium in unstable or acute severe asthma.
- Diabetes (Cipla): "additional blood sugar controls should be considered".
- Infections (Cipla): caution with lung tuberculosis, untreated systemic infections, herpes infection of the eye and fungal, viral or other airway infections, which Cipla says must always be adequately treated.
- After steroid tablets (Cipla): adrenal reserve can stay low "for a considerable time"; Cipla says people whose adrenal function is still impaired should carry a steroid warning card.
- Severe liver disease (Cipla): higher fluticasone levels are expected.
- Pregnancy (Cipla): "not recommended during pregnancy and should be considered only if the expected benefit to the expectant mother is greater than any possible risk to the foetus." Badly controlled asthma also harms pregnancy, so do not stop without medical advice.
- Breastfeeding (Cipla): only if the expected benefit to the mother is greater than any possible risk to the infant.
- Teenagers (Cipla): height should be checked regularly on long-term inhaled steroids. The UK label keeps Flutiform 250/10 for adults.
- Older people (Cipla): no dose change needed.
Side effects
Cipla's table for Maxiflo Inhaler gives no percentages and lists no side effect as common. Selected rows:
| Frequency (Cipla Table 1) | Selected side effects |
|---|---|
| Uncommon (1 in 1,000 to 1 in 100) | Headache, tremor, dizziness, taste change, palpitations, extra heartbeats, worsening asthma, hoarseness, throat irritation, dry mouth, rash, sleep problems, high blood sugar, ankle or leg swelling |
| Rare (1 in 10,000 to 1 in 1,000) | Oral thrush, sinusitis, abnormal dreams, agitation, vertigo, high blood pressure, breathlessness, cough, diarrhoea, indigestion, itching, muscle spasms, weakness |
| Not known | Overactivity, anxiety, depression, aggression or behaviour change (mainly children) |
Blurred vision is listed from post-marketing experience. Cipla's table is laid out like the UK Flutiform table, which describes the Flutiform inhaler, not Maxiflo. Cipla also warns that, with enough dose and time, inhaled steroids can cause adrenal suppression, Cushing's features, lower bone density, cataract, glaucoma and slower growth in young people, and that blurred vision or other visual changes should lead to an eye referral. From formoterol, Cipla lists hypersensitivity reactions, QTc prolongation, low potassium and nausea. Hoarseness and thrush are the effects a mouth rinse after each dose helps with.
When to get urgent help
- An asthma attack your reliever does not ease, or breathing that gets rapidly worse: call 911 (US, Canada), 999 (UK) or 000 (Australia). Cipla calls sudden, progressive deterioration "potentially life-threatening", needing urgent medical assessment. Extra Maxiflo puffs will not stop an attack.
- Wheeze or tightness straight after a puff (paradoxical bronchospasm): use your reliever and get help. Cipla says to stop the inhaler immediately and be assessed.
- Allergy signs: swelling of the face, lips, tongue or throat, hives, or trouble breathing or swallowing. Cipla lists angioedema and anaphylactic reactions with fluticasone.
- Chest pain, a racing or irregular heartbeat or a fit, especially after using more puffs than prescribed: these are among the formoterol overdose effects Cipla lists, and it recommends cardiac monitoring.
- Reduced consciousness (drowsiness, confusion), low blood sugar or a seizure: Cipla names these as typical symptoms of adrenal crisis. The UK Flutiform label lists trauma, surgery, infection or any rapid reduction in dose as possible triggers. Calling emergency services is our advice.
Needing your reliever more often than usual is not an emergency on its own, but Cipla says it means your asthma control is slipping and you should see a doctor soon. Tell any emergency team which inhalers you use, how many puffs you took and when.
Who should not use Maxiflo 250 Inhaler
Contraindication (Cipla): a history of allergy to formoterol, fluticasone or any other component. The UK Flutiform label's only contraindication is the same kind of allergy.
Not recommended, or only with a doctor's agreement:
- children under 12: Cipla says Maxiflo Inhaler "is not recommended for children under 12 years" (safety and efficacy not assessed); the UK label keeps the 250/10 strength for adults;
- relief of sudden symptoms, or first treatment of asthma (Cipla; UK label);
- starting it during a flare (both labels);
- on top of another long-acting beta agonist (UK label);
- COPD, which the UK label says Flutiform should not be used for, although Cipla lists severe COPD;
- ketoconazole, ritonavir or other potent CYP3A4 inhibitors (Cipla also names atazanavir, clarithromycin, indinavir, itraconazole, nelfinavir, saquinavir and telithromycin): Cipla says these "should be avoided unless the benefit outweighs the increased risk of systemic side effects of corticosteroids", and reports Cushing's syndrome and adrenal suppression;
- beta blockers, including glaucoma eye drops: Cipla says people with asthma "should not normally be treated with" them;
- MAO inhibitors or tricyclic antidepressants (including within two weeks of stopping) and medicines that prolong the QTc interval: Cipla says formoterol should be given with "extreme caution";
- surgery with halogenated hydrocarbon anaesthetics: Cipla notes a higher risk of arrhythmias, so tell the anaesthetist.
Ingredients we could not confirm. Cipla's composition lists only the two medicines and the HFA 134a propellant, yet other parts of the same document mention sodium cromoglycate "as an excipient" and say people with galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption "should not take this medicine". Those lines match a Flutiform or dry powder text more than a propellant puffer. If you have one of those conditions or a cromoglycate allergy, read the carton and ask your pharmacist before use.
Prescription and legal status
Fluticasone propionate with formoterol is prescription only in the UK (Flutiform, POM) and Schedule 4 (prescription only) in Australia. We found no product with this combination in FDA records (Drugs@FDA via openFDA) or in Health Canada's Drug Product Database (both checked 14 November 2026), so it is not approved in the US or Canada. Apollo marks Maxiflo 250 Inhaler as a "Prescription drug" in India. This Indian inhaler is not registered with the FDA, the MHRA, the TGA or Health Canada. The FDA says personal importation of unapproved medicines is illegal in most circumstances. Whatever you buy, asthma needs regular review with a doctor or nurse, an inhaler technique check and a written action plan. Check the rules in your country.
Buying genuine Maxiflo
The MHRA warns: "Any medicine not authorised for sale in the UK can be unsafe or ineffective and there is no way of knowing what is in them or the negative health effects they can have." It advises: "Only use UK-registered pharmacies, including online pharmacies displaying the official green cross logo." That warning applies to this Indian inhaler. On arrival, check that the carton and canister say Cipla and Maxiflo 250, list fluticasone propionate 250 mcg and formoterol 6 mcg, show 120 metered doses, a batch number and an expiry date, and that the counter starts at its full reading. None of these checks proves an inhaler is genuine, because packaging can be copied. If your asthma seems less well controlled than on your previous preventer, see your doctor instead of taking extra puffs. If a batch causes unexpected symptoms, get medical advice and report it to the MHRA Yellow Card scheme (UK), FDA MedWatch (US), the TGA (Australia) or Health Canada, as well as to us.
Storage: Cipla says store below 30 C and do not freeze; PharmEasy repeats this, while Apollo gives 20 to 25 C. The canister is pressurised: keep it away from heat and direct sun, and do not puncture or burn it, even when empty (our advice for any aerosol).
Delivery
We ship Maxiflo 250 Inhaler to the US, UK, Australia and Canada in plain packaging with tracking. Delivery takes 7 to 14 business days, so order about three weeks before your current inhaler runs out; at 2 puffs twice a day one inhaler covers 30 days. Shipping is $25 on orders under $149 and free from $149. Details are on our shipping page and in our refund policy.
Related guides
- Rotacaps vs inhaler vs respules: which asthma device gets the dose into your lungs
- Advair vs Symbicort (Seroflo vs Foracort): choosing a combination inhaler
- Generic Advair and Seroflo: what the strength numbers mean
- Budesonide with formoterol inhalers: doses, MART and the trials
- Prednisolone for asthma flare-ups
Related products: Seroflo 250 Inhaler (fluticasone with salmeterol, puffer), Foracort 200 Inhaler (budesonide with formoterol, puffer) and Levolin Inhaler (levosalbutamol reliever).
Sources
- Cipla Limited. MAXIFLO Inhaler (125 and 250) prescribing information, last updated February 2019, accessed 16 November 2026: composition, dosage form, pharmacodynamics, indications, dosage and administration, contraindications, warnings and precautions, drug interactions, hepatic impairment, pregnancy, labour, lactation, paediatric and geriatric use, undesirable effects (Table 1), overdosage, storage, packaging. ciplamed.com
- Flutiform 50/5, 125/5 and 250/10 micrograms per actuation pressurised inhalation, suspension. UK SmPC, Napp Pharmaceuticals, PL 16950/0167 to 0169, revised 4 June 2021, sections 2, 4.1 to 4.4 and 5.2; POM on emc. emc
- healthdirect Australia. Flutiform 250 microgram/10 microgram: indication, Schedule 4, PBS listing. healthdirect
- Advair HFA US prescribing information, GlaxoSmithKline, DailyMed setid dfaca6f9-3277-47b2-319d-1377917cb54c, version 37, effective 23 May 2024: sections 1, 11 and 16. Fluticasone propionate and salmeterol HFA (Prasco), setid 666c5b12-a4f7-4c53-8261-4742b5e5a6df, version 5: section 16. Dulera US prescribing information, Organon, setid 8f399784-f257-4f31-b3dc-368bf2a1864d, version 8, effective 10 July 2026: sections 1, 11 and 16. DailyMed
- Centers for Medicare and Medicaid Services. NADAC 2026 file, as of 11 November 2026, all rows effective 21 October 2026: Advair HFA 230/21 (NDC 00173071720) $35.00808 per gram; fluticasone propionate and salmeterol 230/21 (66993008896) $27.15260 per gram; Dulera 200/5 (78206012601) $25.17560 per gram. data.medicaid.gov
- Central Drugs Standard Control Organisation, India. Fixed dose combinations approved by DCG(I), item 582 (formoterol fumarate 6 mcg with fluticasone propionate 50, 125 or 250 mcg MDI, for asthma and COPD, 14 October 2006). cdsco.gov.in
- Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention 2026 and Summary Guide 2026: low, medium and high daily inhaled corticosteroid doses; spacer advice. ginasthma.org
- Cipla (CiplaMed). Maxiflo Inhaler with Dose Counter monograph: dose counter user guide and cleaning, accessed 16 November 2026. ciplamed.com
- PharmEasy, Apollo Pharmacy and MediBuddy. Maxiflo 250 Inhaler listings (Cipla), accessed 16 November 2026. PharmEasy, Apollo, MediBuddy
- US Food and Drug Administration, Drugs@FDA via openFDA, and Health Canada, Drug Product Database: searches for fluticasone with formoterol (none found), 14 November 2026. Health Canada
- MHRA. 20 million illegal erectile dysfunction pills seized as MHRA warns against risky online buys, 13 February 2026. GOV.UK
- US Food and Drug Administration. Personal Importation. FDA
This page is information, not medical advice. Fluticasone with formoterol is a prescription medicine; your doctor should choose your dose, device and asthma action plan.
Frequently asked questions
What is Maxiflo 250 Inhaler?
A pressurised metered dose inhaler made by Cipla in India. Cipla's prescribing information says each puff delivers 250 mcg of fluticasone propionate (an inhaled steroid) and 6 mcg of formoterol fumarate dihydrate (a long-acting bronchodilator) in an HFA 134a propellant. Each canister has 120 metered doses and a dose counter. It is a twice daily preventer for asthma; Cipla also lists severe COPD.
Is Maxiflo 250 Inhaler the same as Flutiform?
It contains the same two medicines, but the numbers differ. Flutiform 250/10 (UK and Australia) meters 250 mcg fluticasone and 10 mcg formoterol per puff, which the UK label says delivers about 230 mcg and 9.0 mcg. Cipla says each Maxiflo 250 puff delivers 250 mcg and 6 mcg, so it carries less formoterol per puff. We have not found a published study comparing the two, and the Indian inhaler is not registered with the FDA, MHRA, TGA or Health Canada.
How much does Maxiflo 250 Inhaler cost?
As of November 2026, one inhaler is $32, two are $49 and three are $71, which is $32.00, $24.50 and $23.67 an inhaler, or about $0.20 to $0.27 a puff before shipping. Shipping is $25 on all three packs because each is under $149, so one inhaler costs $57 delivered and three cost $96. The pack selector shows the current price.
How do I use Maxiflo 250 Inhaler?
Cipla's dose for asthma from age 12 is 1 to 2 puffs twice a day. Shake before every puff, breathe out, then start a slow deep breath and press the canister once while you keep breathing in, and hold your breath as long as is comfortable. Prime a new inhaler, or one unused for a few days, as your leaflet says (Flutiform uses 4 test puffs). Rinse your mouth and spit after each dose. A spacer can help if pressing and breathing together is hard; tell your doctor if you start or stop one.
Can I use Maxiflo 250 Inhaler during an asthma attack?
No. Cipla says it should not be used to treat acute asthma symptoms that need a fast, short-acting bronchodilator, and that your reliever should be available at all times. Use a reliever such as salbutamol. If the reliever does not help, call emergency services (911, 999 or 000).
Should I choose Maxiflo 125 or 250 Inhaler?
Maxiflo 250 gives 500 mcg of fluticasone a day at 1 puff twice daily and 1,000 mcg at 2 puffs twice daily, which falls in GINA 2026's medium and high ranges for a fluticasone puffer (GINA uses metered doses and Cipla states delivered doses, so treat this as a guide). Maxiflo 125 gives half that. Both have 6 mcg formoterol per puff. Your doctor should choose the lowest strength that keeps your asthma controlled; the UK Flutiform label keeps its 250/10 strength for adults.
Is the inhaler or the Rotacaps version better?
Neither is better in general. The inhaler needs you to press and breathe in at the same time (or use a spacer); Rotacaps need a Rotahaler and a fast, strong breath. Cipla labels the inhaler by what each puff delivers and the capsules by what each contains, so the numbers are not directly comparable. On our current prices the inhaler costs less per dose. Choose the device you can use well, with your doctor or nurse.
Can Maxiflo 250 Inhaler be used for COPD?
Cipla lists it for severe COPD at 2 puffs twice a day, and India approved the combination for asthma and COPD in 2006. The UK Flutiform label says there are no data in COPD and that Flutiform should not be used in patients with COPD; Australia lists it for asthma only. If you have COPD, talk to your doctor first.
What are the side effects of Maxiflo 250 Inhaler?
Cipla lists no common side effects. Uncommon ones include headache, tremor, dizziness, palpitations, hoarseness, throat irritation, dry mouth, worsening asthma, sleep problems and high blood sugar; oral thrush is rare. Wheeze straight after a puff, allergy signs, chest pain or a racing heartbeat need urgent help. Long-term high steroid doses can affect the adrenal glands, bones and eyes.
Who should not use Maxiflo 250 Inhaler?
Anyone allergic to fluticasone, formoterol or another component (Cipla's only contraindication). Cipla does not recommend it under age 12. It is not for attacks or for starting during a flare, should not be combined with another long-acting beta agonist (UK label), and needs a doctor's review with heart rhythm problems, beta blockers, ritonavir, ketoconazole or other strong CYP3A4 inhibitors, MAO inhibitors or tricyclic antidepressants.
Do I need a prescription, and how long does delivery take?
The combination is prescription only in the UK and Australia (Flutiform) and is not approved in the US or Canada; Apollo lists Maxiflo 250 Inhaler as a prescription drug in India. The FDA says personal importation of unapproved medicines is illegal in most circumstances. We ship in plain packaging with tracking in 7 to 14 business days; shipping is $25 under $149 and free from $149.
Medical References
- 1.Cipla. MAXIFLO Inhaler prescribing information (last updated February 2019) — 2019
- 2.Cipla. Maxiflo Inhaler with Dose Counter monograph (user guide and cleaning)
- 3.Flutiform 50/5, 125/5, 250/10 pressurised inhalation: UK Summary of Product Characteristics (Napp) — 2021
- 4.healthdirect Australia. Flutiform 250 microgram/10 microgram
- 5.Advair HFA (fluticasone propionate and salmeterol) US prescribing information — 2024
- 6.Dulera (mometasone furoate and formoterol) US prescribing information — 2026
- 7.CMS. National Average Drug Acquisition Cost (NADAC), as of 11 November 2026 — 2026
- 8.Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention 2026
- 9.CDSCO. Fixed dose combinations approved by DCG(I), item 582 — 2006
- 10.US FDA. Personal Importation
Sources: U.S. National Library of Medicine (DailyMed, PubMed), openFDA
Related articles
Customer Reviews
No reviews yet. Bought Maxiflo 250 Inhaler? Tell other buyers how it went.







